AMPH EBITDA Growth
Amphastar Pharmaceuticals Inc · EBITDA Growth
AMPH EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported-22.92%period ending
AMPH TTM EBITDA YoY % (-79.74% → -22.92%)
Year-over-year change
High-resolution chart · PNG
AMPH ebitda growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Growth |
|---|---|
| -22.9197% | |
| -26.1588% | |
| -23.8752% | |
| -19.9404% | |
| -16.8577% | |
| -3.568% | |
| 15.1668% | |
| 22.8306% | |
| 81.3791% | |
| 77.4908% | |
| 64.2822% | |
| 71.7937% | |
| 13.3534% | |
| 11.4284% | |
| 30.859% | |
| 67.8327% | |
| 207.1342% | |
| 345.1738% | |
| 270.2295% | |
| 111.223% | |
| 54.0174% | |
| -7.2344% | |
| 36.4627% | |
| 74.2863% | |
| 50.868% | |
| 139.7436% | |
| 186.1726% | |
| 341.6632% | |
| 18,056.25% | |
| 88.3903% | |
| -48.2911% | |
| -57.3625% | |
| -99.3991% | |
| -71.2374% | |
| -51.2298% | |
| -77.0032% | |
| -52.2592% | |
| 38.7003% | |
| 295.1025% | |
| 476.9296% | |
| 338.0343% | |
| 361.5032% | |
| 380.0072% | |
| -287.8726% | |
| -215.4025% | |
| -125.7873% | |
| -108.9353% | |
| -79.7414% |